Maurizio Vecchione is the Sr. Vice President for Global Good and Research at Intellectual Ventures in charge of the Global Good Fund. In this role, he oversees IV’s collaboration with Bill Gates to invent and deploy technology specifically focused on improving life in developing countries, as well as the Intellectual Ventures Laboratory and Institute for Disease Modeling. The Global Good Fund is the world’s largest investor in inventions for the benefit of the poorest three billion people on the planet, focusing on disruptive innovation in global health and global development for the benefit of humanity.
With more than 30 years of experience in the technology and life sciences sector, Mr. Vecchione has helped build nine start-ups and launched more than 50 commercial products spanning life-sciences, health technologies, therapeutics and as well as telecommunications, information and material sciences. He most recently served as CEO of Arrogene, which is commercializing a new nanotechnology platform for cancer therapeutics and diagnostics, and as CEO of telemedicine pioneer CompuMed.
As an inventor himself, Mr. Vecchione is named on multiple U.S. patents and patent applications related to imaging, image processing, nano-bio-polymer and telecommunications technologies.